Author: Bill Ross | Reading Time: 4 minutes | Published: February 24, 2026 | Updated: April 2, 2026 A specialized life sciences firm needed more than a website translation. They needed a complete digital strategy built for U.S. search behavior, buyer expectations, and regulatory credibility. Breaking into the U.S. pharmaceutical and biotech market is one of the hardest things a foreign company can do online. American buyers, procurement teams, and research partners search differently, evaluate credibility differently, and expect a digital experience that feels native to their market. When a UK-based life sciences company came to us, they had strong science and deep industry relationships across Europe. What they did not have was any meaningful visibility in U.S. search results. We changed that. Pharmaceutical and biotech decision-makers in the United States rely heavily on organic search during the research and vendor evaluation process. A company that does not appear in those search results simply does not exist to that audience. For international firms, the challenge is even steeper: Google treats geographic relevance, content authority, and trust signals (what Google calls E-E-A-T, or Experience, Expertise, Authoritativeness, and Trustworthiness) as ranking factors that directly affect whether your pages show up for U.S.-based queries. If your content reads like it was written for a different market, or if your site lacks the technical and structural signals Google expects, your pages will be buried beneath domestic competitors who have those pieces in place. Five things every international life sciences company should know about U.S. search: The client is a mid-sized life sciences company headquartered in the United Kingdom. They provide contract research, analytical testing, and regulatory consulting services to pharmaceutical manufacturers and biotech startups. Their team includes PhD-level scientists and former regulatory professionals with decades of combined experience. In Europe, they had built a strong reputation through conferences, journal citations, and long-standing client relationships. But when it came to the U.S. market, their digital presence told a very different story. The company’s website had been built primarily for a UK audience. Service descriptions used terminology and phrasing common in the European market but unfamiliar to American searchers. Their site was hosted on servers in the UK, which created latency issues for U.S. visitors and sent geographic signals to Google that worked against domestic rankings. They had almost no backlinks from U.S.-based domains, and their Google Analytics data showed that fewer than 8% of their organic visitors came from the United States. Beyond the technical gaps, the content itself was thin. Most service pages ran under 300 words and lacked the depth Google expects from sites in the pharmaceutical and biotech space. There were no resources, case studies, or technical articles that demonstrated real-world expertise. For a company competing in a category where Google applies its strictest content quality standards, this was a serious liability.
“In life sciences, credibility is everything. If your website does not demonstrate the same rigor your lab work does, U.S. buyers will move on to a competitor whose site does.” – Strategy Team at Emulent Marketing
We started with a full audit of the client’s existing site, their competitors’ U.S. search footprints, and the keyword patterns that American pharmaceutical and biotech professionals actually use when searching for contract research and regulatory consulting services. U.S. searchers used different terminology than UK searchers for many of the same services. Phrases like “FDA regulatory consulting,” “cGMP compliance testing,” and “pharmaceutical analytical services” carried high search volume in the U.S. but appeared nowhere on the client’s existing site. We mapped over 120 high-intent keyword targets across four service categories, then grouped them by searcher role: procurement, scientific, and regulatory. We rebuilt the client’s website on WordPress, migrating from their previous CMS to a platform that gave us full control over technical SEO elements like schema markup, page speed, crawl structure, and mobile responsiveness. We created a U.S.-specific subdirectory structure so Google could clearly associate relevant pages with the American market. Hosting moved to U.S.-based servers through WPEngine, which cut average page load time for American visitors from 4.2 seconds to 1.1 seconds. Each service category received a pillar page running 2,000 or more words, written with input from the client’s scientific team to meet the accuracy standards Google requires for YMYL content. We built supporting articles around specific regulatory topics, testing methodologies, and industry trends that U.S. pharmaceutical companies actively search for. Every article included author attribution tied to named scientists on the client’s team, which reinforced the E-E-A-T signals Google uses to evaluate expertise in this field. We launched a targeted outreach campaign focused on U.S. pharmaceutical trade publications, biotech industry directories, and university research partnerships. Over six months, we secured placements and backlinks from 34 U.S.-based domains with high authority scores. We also listed the client in relevant U.S. industry directories and professional associations, creating consistent NAP (Name, Address, Phone) citations that supported local and national search visibility. U.S.-based organic sessions grew from roughly 1,400 per month to over 4,400 per month. The traffic was not just higher in volume; it was higher in quality, with average session duration increasing by 62% and bounce rate dropping by 19 percentage points. Before the engagement, the client ranked on the first page of Google for zero U.S.-targeted keywords. Nine months later, 23 of their primary keyword targets appeared on page one, including competitive terms like “pharmaceutical regulatory consulting USA” and “biotech analytical testing services.” The client received 41 contact form submissions from U.S.-based pharmaceutical and biotech companies during the first nine months, compared to just 3 in the nine months before the engagement. Of those 41 leads, 12 converted to active sales conversations. Each backlink came from a relevant, reputable source in the pharmaceutical, biotech, or scientific research space. No paid links. No directory spam. Just genuine placements earned through quality content and targeted outreach. International life sciences companies often assume that a strong reputation in one market will translate automatically to another. It does not. The U.S. pharmaceutical and biotech search results are dominated by domestic companies that have spent years building content libraries, earning backlinks, and refining their technical SEO. Entering that market requires a deliberate, structured approach.
“You cannot shortcut authority in pharmaceutical search. Google holds life sciences content to its highest standard, and the companies that earn top rankings are the ones willing to invest in real depth, not just more pages.” – Strategy Team at Emulent Marketing
A few principles that apply broadly across the life sciences industry: Match your content to U.S. search behavior, not just U.S. English. Translating British English to American English is only the starting point. The terminology, the regulatory references, and the way American buyers describe their needs are all different. Your keyword strategy should reflect how U.S. professionals actually search, not how your internal team describes your services. Treat your website as a credibility tool, not a brochure. In pharmaceutical and biotech search, thin content is a ranking liability. Google’s quality guidelines for YMYL topics require demonstrated expertise, and that means publishing content written or reviewed by credentialed professionals on your team. Build authority through relationships, not volume. One backlink from a respected U.S. pharmaceutical trade publication is worth more than fifty links from generic business directories. Focus your outreach on sources that your target audience already reads and trusts. Entering a new market takes more than a website redesign. It takes a strategy grounded in how search engines evaluate credibility and how buyers in that market actually find and vet potential partners. If your company is looking to grow its U.S. presence through organic search, the Emulent team can help you build the kind of digital foundation that earns rankings, trust, and real business results. Contact the Emulent Team to talk about your SEO and content strategy. How We Positioned a UK Life Sciences Company as a U.S. Authority in Google Search

Why U.S. Search Visibility Matters for International Life Sciences Companies
Who Was the Client?
What Was Holding Them Back?
How We Built a U.S.-Focused Search Strategy from the Ground Up
What did we find in the keyword research?
How did we restructure the site for U.S. search?
What kind of content did we create?
How did we build U.S. domain authority?
The Numbers Tell the Story
217% increase in U.S. organic traffic within 9 months
From page 6 to page 1 for 23 priority keywords
41 qualified U.S. leads generated through organic search
34 new U.S. backlinks from high-authority domains
What Other Life Sciences Companies Can Learn from This
Ready to Build U.S. Search Authority in Life Sciences?
- Our Story
- What We Do
Website Optimization
What's Your Situation
- What We’ve Done
- Resource Center
- Let’s Talk!